Parathyroid hormone receptor activation and stem and progenitor cell expansion

Compositions for nasal administration of pharmaceuticals

Flowable implant with crosslinkable surface membrane

Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device

Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces

Method for controlled release of parathyroid hormone from cross-linked hyaluronic acid hydrogel

Device, system and methods for the oral delivery of therapeutic compounds

Method of drug delivery for bone anabolic protein

Poly-hapten with topical hormone alopecia hair regrowth system

Parathyroid hormone analogs and uses thereof

Peptide pharmaceutical for oral delivery

PREVENTIVE AND/OR THERAPEUTIC AND/OR AGGRAVATION SUPPRESSING AGENT FOR HUMAN ARTHRITIS DEFORMANS

Composition for nasal administration and method for preparing same

METHOD OF DRUG DELIVERY FOR PTH, PTHrP AND RELATED PEPTIDES

Peptide pharmaceutical for oral delivery

PTH-CONTAINING THERAPEUTIC/PROPHYLACTIC AGENT FOR OSTEOPOROSIS, CHARACTERIZED IN THAT PTH IS ADMINISTERED ONCE A WEEK IN A UNIT DOSE OF 100 TO 200 UNITS

Pharmaceutical compositions for sustained release delivery of peptides

Stable formulations for parenteral injection of peptide drugs

MULTIPLE MYELOMA PROGNOSIS AND TREATMENT

Oral Delivery of Peptides

Methods useful in the treatment of bone resorption diseases

Methods of correcting imbalance between bone resorption and bone formation and kits and compositions therefor

THERAPEUTIC CALCIUM PHOSPHATE PARTICLES AND METHODS OF MAKING AND USING SAME

Pharmaceutical compositions and related methods of delivery

Modified amino acid for the inhibition of platelet aggregation

5-CNAC as oral delivery agent for parathyroid hormone fragments

COMPOSITION FOR TRANSMUCOSAL DELIVERY OF POLYPEPTIDES

Peptide pharmaceutical for oral delivery

Protecting and repairing cartilage and musculoskeletal soft tissues

Swallowable drug delivery device and method of delivery

Pharmaceutical compositions and related methods of delivery

Supplemented matrices for the repair of bone fractures

Method for controlled release of parathyroid hormone from encapsulated poly(lactic-glycolic)acid microspheres

MICRONEEDLE DEVICE

Method and device for transdermal delivery of parathyroid hormone using a microprojection array

PREPARATION AND USE OF HIGH-PURITY HEMOPARATIDE (HPTH-1-37) FOR THE TREATMENT OF INFLAMMATORY SCALING DISEASES OF THE SKIN

PHARMACEUTICAL COMPOSITIONS AND RELATED METHODS OF DELIVERY

Parathyroid hormone receptor activation and stem and progenitor cell expansion

PHARMACEUTICAL COMPOSITION

MAMMALIAN HYPOTHALAMIC NUTRIENT MODULATION OF GLUCOSE METABOLISM

Method for altering drug pharmacokinetics based on medical delivery platform

PULSE PARATHYROID HORMONE FOR TREATMENT OF THE HEMATOPOIETIC SYNDROME, STROMAL CELL LOSS, AND VASCULAR INJURY RESULTING FROM ACUTE EXPOSURE TO LETHAL RADIATION

METHODS OF TREATMENT USING BIASED LIGANDS FOR RECEPTORS SUCH AS THE PTH RECEPTOR

PREVENTIVE AND/OR THERAPEUTIC AND/OR AGGRAVATION SUPPRESSING AGENT FOR HUMAN ARTHRITIS DEFORMANS

COMPOSITION FOR MUCOSAL ADMINISTRATION CONTAINING AGENT FOR ENHANCING MUCOSAL ABSORPTION OF PEPTIDE DRUG, AND ADMINISTRATION METHOD THEREOF

Swallowable drug delivery device and methods of drug delivery

Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device

COMPOSITIONS AND METHODS FOR ORAL DRUG DELIVERY

Methods and compositions for oral administration of insulin

METHODS AND COMPOSITIONS FOR TREATMENT OF NEUROLOGICAL DISORDERS

COMPOSITIONS AND METHODS OF STEM CELL THERAPY FOR AUTISM

METHOD OF DRUG DELIVERY FOR BONE ANABOLIC PROTEIN

Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use

Methods useful in the treatment of bone resorption diseases

PHARMACOPERONES FOR CORRECTING DISEASE STATES INVOLVING PROTEIN MISFOLDING

Cosmetic preparations containing PTH fragments

Sustained release systems and preparation method thereof

PHARMACEUTICALLY ACCEPTABLE FORMULATIONS/COMPOSITIONS FOR PEPTIDYL DRUGS

Stabilizing alkylglycoside compositions and methods thereof

Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces

PHARMACEUTICAL SYSTEM FOR TRANS-MEMBRANE DELIVERY

Injectable Radio-Opaque Compositions for Tissue Augmentation

Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents

PEPTIDE PHARMACEUTICALS FOR NASAL DELIVERY

EDIBLE GELATIN BOWEL PREPARATION AND BOWEL CLEANSING METHOD

USE OF A PEPTIDE AS A THERAPEUTIC AGENT

Method of drug formulation of compositions comprising crystalline microparticle surfaces

Compositions and methods for promoting bone formation

METHODS COMPOSITIONS AND ARTICLE OF MANUFACTURE FOR MODULATING BONE GROWTH

Stabilizing alkylglycoside compositions and methods thereof

Complex consisted of a polysaccharide and an HBP

COMPOSITIONS AND METHODS FOR ENHANCED MUCOSAL DELIVERY OF PARATHYROID HORMONE

GRAS COMPOSITION FOR INTRANASAL DELIVERY OF PARATHYROID HORMONE

Apparatus and method for transdermal delivery of parathyroid hormone agents

Treatment of early-stage osteoarthritis

Apparatus for transdermal delivery of parathyroid hormone agents

Treatment of arthritis with parathyroid hormone

PTHrP-DERIVED MODULATORS OF SMOOTH MUSCLE PROLIFERATION

RESCUE OF GONADOTROPIN RELEASING HORMONE RECEPTOR MUTANTS

Fusion proteins of collagen-binding domain and parathyroid hormone

Apparatus and method for transdermal delivery of parathyroid hormone agents

Parathyroid hormone receptor activation and stem and progenitor cell expansion

COMPOSITION FOR TRANSMUCOSAL DELIVERY OF POLYPEPTIDES

PHARMACEUTICAL COMPOSITIONS AND RELATED METHODS OF DELIVERY

Antibacterial compositions for drug administration

Absorption enhancers such as E.G. BHT, BHA or propyl gallate

Method of correcting imbalance between bone resorption and bone formation and kits and compositions therefor

Stable composition comprising a PTHrP analogue

Controlled-release otic structure modulating and innate immune system modulating compositions and methods for the treatment of otic disorders

Treatment for nicotine-induced lung disease using peroxisome proliferator-activated receptor gamma agonists

STABILIZING ALKYLGLYCOSIDE COMPOSITIONS AND METHODS THEREOF

Compounds and compositions for delivering active agents

Peptide pharmaceutical for oral delivery

Stabilized Parathyroid Hormone Composition Comprising Parathyroid Hormone, Buffer and Stabilizing Agent

Stabilizing alkylglycoside compositions and methods thereof

Gastro-Retentive System for the Delivery of Macromolecules

Remedies for ischemia

Stabilized protein-containing formulations

COMPOSITIONS FOR DELIVERING PARATHYROID HORMONE AND CALCITONIN

5-CNAC AS ORAL DELIVERY AGENT FOR PARATHYROID HORMONE FRAGMENTS

PARATHYROID HORMONE TREATMENT FOR ENHANCED ALLOGRAFT AND TISSUE-ENGINEERED RECONSTRUCTION OF BONE DEFECTS

Method of treating osteoporosis comprising administration of PTHrP analog

Osteogenic and anti-adipogenic oxysterols

Stabilizing alkylglycoside compositions and methods thereof

Transthyretin variants

Compositons for nasal administration of pharmaceuticals

Implantable device for controlled, extended delivery of parathyroid hormone

CONTROL OF DRUG RELEASE BY TRANSIENT MODIFICATION OF LOCAL MICROENVIRONMENTS

Methods useful in the treatment of bone resorption diseases

Transdermal sustained release drug delivery

Pulmonary pharmaceutical formulations

Parathyroid hormone receptor activation and hematopoietic progenitor cell expansion

GSK-3 INHIBITORS

Phospholipid-based powders for drug delivery

Parathyroid hormone analogues and methods of use

Biased Ligands for Receptors Such as the PTH Receptor

Methods for hematopoietic stimulation

Parathyroid Hormone Analogues and Methods of Use

Methods for Tissue Engineering

TREATMENT OF BONE DISORDERS WITH SKELETAL ANABOLIC DRUGS

Use of Parathyroid Hormone for Treating Periodontal Disease and for Other Dental Applications

TOPICAL COMPOSITIONS COMPRISING A MACROMOLECULE AND METHODS OF USING SAME

Umbilical Cord Stem Cell Composition & Method of Treating Neurological Diseases

MODIFIED AMINO ACID FOR THE INHIBITION OF PLATELET AGGREGATION

Solvent-cast microprotrusion arrays containing active ingredient

Stabilizing alkylglycoside compositions and methods thereof

Activating extraction of demineralized bone matrix

Fibrin Compositions Containing Strontium Compounds

Pharmaceutical Composition

Delivery device and method for forming the same

Use of GLP-2 in a combination treatment for bone-related disorders

METHOD FOR ALTERING DRUG PHARMACOKINETICS BASED ON MEDICAL DELIVERY PLATFORM

Use of bisphosphonates for the treatment of osteogenesis imperfecta

Compositions for buccal delivery of parathyroid hormone

METHOD FOR FOSTERING BONE FORMATION AND PRESERVATION

Method for fostering bone formation and preservation

Parathyroid hormone analogues and methods of use

Aryl ketone compounds and compositions for delivering active agents

COMPOSITIONS FOR DELIVERING PARATHYROID HORMONE AND CALCITONIN

Orally administering parathyroid hormone and calcitonin

PTH FORMULATIONS FOR INTRANASAL DELIVERY

METHODS AND DEVICES FOR ADMINISTRATION OF SUBSTANCES INTO THE INTRADERMAL LAYER OF SKIN FOR SYSTEMIC ABSORPTION

Treatment Of Bone Metastases By Means Of Pth Receptor Agonists

Parathyroid hormone antagonists and uses thereof

METHOD AND IMPLANTABLE DEVICE WITH RESERVOIR ARRAY FOR PRE-CLINICAL IN VIVO TESTING

Therapeutic agents for osteopenia

Pulmonary delivery of active fragments parathyroid hormone

Method for fostering bone formation and preservation

METHOD FOR FOSTERING BONE FORMATION AND PRESERVATION

METHOD OF MODULATING HEMATOPOIETIC STEM CELLS AND TREATING HEMATOLOGIC DISEASES USING INTRANASAL PARATHYROID HORMONE

Apparatus and Method for Transdermal Delivery of Parathyroid Hormone Agents to Prevent or Treat Osteopenia

Regulation of cell proliferation and differentiation using topically applied nucleic acid molecules

Pharmaceutical compositions for sustained release delivery of peptides

Analogs of parathyroid hormone

Stabilizing alkylglycoside compositions and methods thereof

Parathyroid hormone receptor activation and stem and progenitor cell expansion

Compositions capable of facilitating penetration across a biological barrier

Parathyroid hormone analogues and methods of use

THREE-COMPONENT POLYANHYDRIDE COPOLYMERS AND A METHOD OF FORMING THE SAME

Use of film-forming hair care polymers from the group of polyurethanes and pharmaceutical preparations and patches that contain these polymers

COMPOSITIONS AND METHODS FOR ENHANCED MUCOSAL DELIVERY OF PARATHYROID HORMONE

Bone densifying agent characterized by use of cathepsin K inhibitor with PTH

COMPOSITIONS CAPABLE OF FACILITATING PENETRATION ACROSS A BIOLOGICAL BARRIER

Transmucosal Administration Agent Containing Pth

Methods for inhibiting osteoclast differentiation, formation, or function and for increasing bone mass

Stable therapeutic formulations

METHOD FOR TREATING OSTEOPOROSIS BY INTRANASAL DELIVERY OF TERIPARATIDE WITH AN ANTI-RESORPTIVE AGENT

Compositions capable of facilitation penetration across a biological barrier

Compositions and methods for enhanced mucosal delivery of parathyroid hormone

Conformationally constrained parathyroid hormones with alpha-helix stabilizers

Method of reducing the risk of bone fracture

Parathyroid hormone (pth) containing pharmaceutical compositions for oral use

Intravenous essential fatty acid emulsion

COMPOSITIONS AND METHODS FOR ENHANCED MUCOSAL DELIVERY OF PARATHYROID HORMONE

COMPOSITIONS AND METHODS FOR ENHANCED MUCOSAL DELIVERY OF PARATHYROID HORMONE

Polymeric delivery agents and delivery agent compounds

Fast-acting oral peptide pharmaceutical products

Regulation of cell proliferation and differentiation using topically applied peptides

COMPOSITIONS AND METHODS FOR THE PULMONARY DELIVERY OF AEROSOLIZED MEDICAMENTS

Parathyroid hormone analogues and methods of use

BIOMARKERS FOR THE EFFICACY OF CALCITONIN AND PARATHYROID HORMONE TREATMENT

Compounds and compositions for delivering active agents

METHOD OF ENHANCING TRANSMUCOSAL DELIVERY OF THERAPEUTIC COMPOUNDS

Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces

Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents

Devices, Compositions and Methods for the Pulmonary Delivery of Aerosolized Medicaments

Stabilized teriparatide solutions

Stabilized teriparatide solutions

Local treatment of bone defects

Methods and compositions for treating degenerative bone disorders

Agents and methods for enhancing bone formation

Parathyroid hormone receptor activation and hematopoietic progenitor cell expansion

Compositions for nasal administration of pharmaceuticals

Conformationally constrained parathyroid hormone (PTH) analogs with lactam bridges

Absorption enhancers such as e.g. BHT, BHA or propyl gallate

5-CNAC as oral delivery agent for parathyroid hormone fragments

Methods useful in the treatment of bone resorption diseases

Use of a parathyroid hormone peptide analogs for the treatment of vaginal atrophy

Stable pharmaceutical dosage forms of teriparatide

Method for treating depression and/or anxiety

PEPTIDE PHARMACEUTICAL FORMULATIONS

Control of drug release by transient modification of local microenvironments

Compounds and compositions for delivering active agents

Seed tear resistant scaffold

Stabilized preparation containing protein

Multi-compartment delivery system

Supplemented matrices for the repair of bone fractures

Synthetic biomaterials having incorporated therein bioactive factors through enzymatically degradable linkages

Stable aerosol formulations of peptides and protein with non-cfc propellants

Method of delivering parathyroid hormone to a human

Uptake of macromolecules

Modified amino acid for the inhibition of platelet aggregation

Method for fostering bone formation and preservation

Method of increasing bone toughness and stiffness and reducing fractures

GRAS composition for enhanced mucosal delivery of parathyroid hormone

Method of treating osteoporosis using intranasal parathyroid hormone

Use of thyrotropin for regeneration of bone

Treatment of bone disorders with skeletal anabolic drugs

Use of PTHrP antagonists for treating renal cell carcinoma

Use of GLP-2 and related compounds for the treatment, prevention, diagnosis, and prognosis of bone-related disorders and calcium homeostasis related syndromes

Compositions and methods for enhanced mucosal delivery of parathyroid hormone

Compounds and compositions for delivering active agents

Lactone bearing absorbable polymers

PTHrP-derived modulators of smooth muscle proliferation

Method for fostering bone formation and preservation

Apparatus and method for transdermal delivery of parathyroid hormone agents

Method for monitoring treatment with a parathyroid hormone

Protein formulations

Method for pharmacoperones correction of GnRHR mutant protein misfolding

Agents for preventing and treating thrombocytopenia

Method of increasing bone toughness and stiffness and reducing fractures

Method for reducing the risk of cancer

Methods for accelerating bone, cartilage, and connective tissue growth

Compounds and compositions for delivering active agents

Peg-binding pth or peg-binding pth derivative

Methods compositions and articles of manufacture for modulating bone growth

Sustained release drug formulations containing a carrier peptide

Method and device for delivery of high molecular weight substances

Method for treating bone loss using parathyroid hormone

Pharmaceutical component based on human parathyroid hormone and a pharmaceutical composition for intranasal administration comprising the component

Composition and apparatus for transdermal delivery

Compounds and compositions for delivering active agents

Intradermal delivery of substances

Intradermal delivery of substances

Intradermal delivery of substances

Stabilized reverse micelle compositions and uses thereof

Methods and composition for delivering nucleic acids and/or proteins to the intestinal mucosa

Methods of screening for apoptosis-controlling agents for bone anabolic therapies and uses thereof

Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin D derivatives and parathyroid hormone

Cyclic analogs of human parathyroid hormone for the treatment of conditions characterized by hyperproliferative skin cells

Compositions capable of facilitating penetration across a biological barrier

GSK-3 inhibitors

Compositions for delivering parathyroid hormone and calcitonin

Method for promoting bone growth

Stabilized formulation of parathyroid hormone

Remedies for bone loss

Use of bisphosphonates for the treatment of osteogenesis imperfecta

Method for treating amyotrophic lateral sclerosis

Method for delivering interferons to the intradermal compartment